Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7745391 Human thrombospondin polypeptide

Patent 7745391 was granted and assigned to COMPUGEN LTD on June, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
‌
COMPUGEN LTD
Date Filed
May 31, 2006
Date of Patent
June 29, 2010
Patent Application Number
11443428
Patent Citations Received
‌
US Patent 12129311 Cyclic peptide combinatorial libraries
0
‌
US Patent 12064407 Endogenous retrovirus-k (ERVK) encodes an alternate envelope protein
0
‌
US Patent 12084722 Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel disease
0
‌
US Patent 12091662 Compositions for modulating tau expression
0
‌
US Patent 11702466 Fusion protein comprising a blood-brain barrier (BBB)-crossing single domain antibody Fc5, an immunoglobulin Fc fragment and a beta-amyloid binding polypeptide (ABP)
0
‌
US Patent 11744846 Allele specific modulators of P23H rhodopsin
‌
US Patent 11753443 Conjugated hepcidin mimetics
‌
US Patent 11767520 Compositions and methods for treating lung inflammation
‌
US Patent 11781135 Methods for treating Alzheimer's disease
‌
US Patent 11826410 Peptides and combination of peptides for use in immunotherapy against various cancers
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7745391
Patent Primary Examiner
‌
David J. Steadman

Find more entities like US Patent 7745391 Human thrombospondin polypeptide

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.